We found that blocking PI3K activation in tumor cells impaired the E2-induced upregulation of CD47 (Supplemental Figure 6B), suggesting that activation of CD47 by E2 is likely to be mediated through the interaction with ER followed by activation of the PI3K signaling. Here, CD47 is linked to neoplasm.